SMIF Polyclonal Antibody

    • Catalog No.:YT4343
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human;Mouse
      • Target:
      • SMIF
      • Fields:
      • >>RNA degradation
      • Gene Name:
      • DCP1A
      • Protein Name:
      • mRNA-decapping enzyme 1A
      • Human Swiss Prot No:
      • Q9NPI6
      • Mouse Swiss Prot No:
      • Q91YD3
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human DCP1A. AA range:111-160
      • Specificity:
      • SMIF Polyclonal Antibody detects endogenous levels of SMIF protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:20000.. IF 1:50-200
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • DCP1A;SMIF;mRNA-decapping enzyme 1A;Smad4-interacting transcriptional co-activator;Transcription factor SMIF
      • Observed Band(KD):
      • 75kD
      • Background:
      • Decapping is a key step in general and regulated mRNA decay. The protein encoded by this gene is a decapping enzyme. This protein and another decapping enzyme form a decapping complex, which interacts with the nonsense-mediated decay factor hUpf1 and may be recruited to mRNAs containing premature termination codons. This protein also participates in the TGF-beta signaling pathway. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Feb 2014],
      • Function:
      • function:Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP. Contributes to the transactivation of target genes after stimulation by TGFB1.,similarity:Belongs to the DCP1 family.,subcellular location:Predominantly cytoplasmic, in processing bodies (PB). Nuclear, after TGFB1 treatment. Translocation to the nucleus depends on interaction with SMAD4.,subunit:Forms a complex with EDC3, DCP2, DDX6 and EDC4/HEDLS, within this complex directly interacts with EDC3. Binds DCP1B, UPF1 and SMAD4. Part of a cytoplasmic complex containing proteins involved in mRNA decay, including XRN1 and LSM1. Interacts with PNRC2.,tissue specificity:Detected in heart, brain, placenta, lung, skeletal muscle, liver, kidney and pancreas.,
      • Subcellular Location:
      • Cytoplasm, P-body . Nucleus . Co-localizes with NANOS3 in the processing bodies (By similarity). Predominantly cytoplasmic, in processing bodies (PB) (PubMed:16364915). Nuclear, after TGFB1 treatment. Translocation to the nucleus depends on interaction with SMAD4 (PubMed:11836524). .
      • Expression:
      • Detected in heart, brain, placenta, lung, skeletal muscle, liver, kidney and pancreas.
      • Products Images
      • Western Blot analysis of various cells using SMIF Polyclonal Antibody
      • Western blot analysis of lysates from Jurkat cells, using DCP1A Antibody. The lane on the right is blocked with the synthesized peptide.
      • Immunohistochemical analysis of paraffin-embedded human Gastric adenocarcinoma. 1, Antibody was diluted at 1:200(4° overnight). 2, Tris-EDTA,pH9.0 was used for antigen retrieval. 3,Secondary antibody was diluted at 1:200(room temperature, 45min).